NOVOMATIC extends research cooperation with the Medical University of Vienna
Company -
EUR 120,000 for research projects on addiction research and addiction therapy
NOVOMATIC has been working successfully with the Medical University of Vienna (MedUni Vienna) in the field of addiction prevention since 2006. The cooperation has now been extended for another two years.
"Cooperations in the field of addiction prevention, science and research form part of NOVOMATIC’s corporate responsibility. This commitment is not limited to Austria, but instead takes place in all countries in which we operate," emphasizes Dr. Eva Glawischnig, Head of Group Corporate Responsibility & Sustainability at NOVOMATIC. As part of this two-year collaboration, NOVOMATIC provides support for research projects on addiction research and addiction therapy worth EUR 120,000.
In addition to the treatment work, there is also specific research work on prevention and therapy at the MedUni Vienna in Vienna’s General Hospital (AKH). Professor Gabriele Fischer enjoys international recognition as head of the drug outpatient clinic, addiction research and addiction therapy at the MedUni Vienna due to her in-depth research work. For example, she advises the United Nations (UN) and the World Health Organization (WHO) as an expert. "Part of the research projects is only possible because of the co-financing of private sponsors. NOVOMATIC has been making a substantial contribution for years to support independent research work," said Prof. Fischer.
